Thomas M. Hallam's Insider Trades & SAST Disclosures
Thomas M. Hallam's most recent trade in Palisade Bio Inc was a trade of 40,000 Common Stock, par value $0.01 done at an average price of $0.3 . Disclosure was reported to the exchange on Aug. 16, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Thomas M. Hallam.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Palisade Bio Inc | Thomas M. Hallam | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 16 Aug 2022 | 40,000 | 57,592 | - | 0.3 | 10,000 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Thomas M. Hallam | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Aug 2022 | 40,000 | 40,000 | - | - | Series 2 Common Stock Purchase Warrant | |
| Palisade Bio Inc | Thomas M. Hallam | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Aug 2022 | 40,000 | 40,000 | - | - | Series 1 Common Stock Purchase Warrant | |
| Palisade Bio Inc | Thomas M. Hallam | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 28 Mar 2022 | 10,000 | 17,592 | - | 1.2 | 11,800 | Common Stock |
| Palisade Bio Inc | Thomas M. Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 156,600 | 156,600 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges